ag 1295 has been researched along with Granulocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahboobi, S | 1 |
| Uecker, A | 1 |
| Sellmer, A | 1 |
| Cénac, C | 1 |
| Höcher, H | 1 |
| Pongratz, H | 1 |
| Eichhorn, E | 1 |
| Hufsky, H | 1 |
| Trümpler, A | 1 |
| Sicker, M | 1 |
| Heidel, F | 1 |
| Fischer, T | 1 |
| Stocking, C | 1 |
| Elz, S | 1 |
| Böhmer, FD | 1 |
| Dove, S | 1 |
1 other study available for ag 1295 and Granulocytic Leukemia
| Article | Year |
|---|---|
Novel bis(1H-indol-2-yl)methanones as potent inhibitors of FLT3 and platelet-derived growth factor receptor tyrosine kinase.
Topics: Acute Disease; Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Cell Line; Cell Line, Tumor | 2006 |